For years, weight loss has been sold as a simple math problem: eat less, move more, and the pounds will melt away. But if that were true, we wouldn’t have an obesity epidemic affecting over 40 percent of adults in the U.S.

Now, a new class of medications—GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are changing the game. People who have struggled with their weight for years are seeing real, lasting results. But with that success has come controversy.

Some claim these medications are a “quick fix.” Others argue they’re unnecessary if people just “try harder.” Meanwhile, patients who have battled their weight for decades are left wondering: Is this finally the solution I’ve been waiting for?

As a triple board-certified physician in internal medicine, obesity medicine, and lifestyle medicine, I’ve seen firsthand how powerful these medications can be—but also how much misinformation surrounds them. So, let’s break it down: What do these medications really do? Who are they for? And what happens if you stop taking them?

GLP-1 medications: a game-changer for weight loss

Imagine your body has a built-in thermostat for weight. If you lose pounds through diet alone, your body fights back—by ramping up hunger, slowing metabolism, and making food seem irresistible. This is why 95 percent of people regain lost weight.

GLP-1 medications change that.

Originally developed to treat diabetes, these drugs mimic a natural hormone that helps regulate blood sugar and appetite. They:

• Reduce hunger. You feel full sooner.
• Decrease cravings. That nagging urge to snack disappears.
• Help regulate blood sugar, which can lower the risk of diabetes.

The results? Patients lose, on average, 5 to 20 percent of their body weight—something that was once only possible with bariatric surgery.

The biggest misconceptions about GLP-1 medications

1. Myth: “They’re just a shortcut.” This is one of the most harmful myths out there.

If obesity were simply about willpower, we wouldn’t see people fighting their weight for years despite endless dieting, exercise, and frustration. Obesity is a hormonal, metabolic condition, not a character flaw.

GLP-1 medications don’t make weight loss “easy”—they make it possible. They level the playing field so patients can adopt healthier habits without battling overwhelming hunger and cravings.

2. Myth: “GLP-1 medications always fail because you gain all the weight back.” The truth? Many people will regain weight after stopping—just like someone with high blood pressure would see their numbers go up if they stopped taking their medication. This isn’t failure. It’s simply biology.

Obesity is a chronic condition, and like any chronic disease, it requires long-term management. That doesn’t mean you’re locked into medication forever—some people transition to lifestyle-only approaches—but for many, staying on treatment is what helps keep the weight off.

3. Myth: “You don’t need medication if you just eat healthy and exercise.” Would we ever say, “You don’t need insulin—just eat better!” to a diabetic? Of course not.

Or tell someone with depression to “just think positive and snap out of it”? That would be dismissive and harmful.

Obesity, like diabetes and depression, is a medical condition with biological roots—not a failure of willpower. Lifestyle changes matter—a lot. But for many people, they aren’t enough on their own. GLP-1s make those changes more effective by helping people control hunger and develop sustainable habits.

These medications aren’t a replacement for healthy eating, movement, sleep, and stress management. They’re a tool—one that makes long-term success far more achievable.

Who should consider GLP-1 medications?

GLP-1s are approved for individuals with:

• A BMI over 30 (or over 27 with conditions like diabetes or high blood pressure).
• A history of struggling with weight loss despite serious efforts.

They’re not for everyone. Some people experience side effects like nausea, vomiting, constipation, or diarrhea. Others may have medical conditions that make them unsuitable. That’s why the best approach is a personalized one—working with a doctor trained in obesity medicine to find the right strategy for you.

The future of obesity medicine

We’re in a new era of obesity treatment. The days of blaming patients for their weight are fading, and science is finally catching up to what many of us in obesity medicine have known for years: Obesity isn’t a lack of effort. It’s a chronic condition that deserves real treatment.

GLP-1 medications are just the beginning. Research is advancing rapidly, and in the next few years, we’ll see even more effective treatments.

The bottom line? If you’ve spent years feeling like you’re fighting your own body, it’s not your fault. And more importantly—there’s help.

If you’ve been wondering whether GLP-1s are right for you, talk to a doctor who understands obesity medicine. The right treatment can be life-changing.

This essay is cited in the KevinMD record on GLP-1 drugs.
Nisha Kuruvadi is an internal medicine physician.